After a recent period of declining share prices, Eli Lilly has pivoted investor focus with a major strategic push centered on ...
The biotechnology sector is characterized by significant price swings, and Regeneron Pharmaceuticals is currently navigating one such period. Although the co ...
The investment case for BioNTech presents a complex picture, caught between significant company-specific advancements and broader industry pressures. While t ...
The release of unexpectedly robust Phase 3 clinical trial data this week by healthcare giant Johnson & Johnson failed to move ...
The performance of Amphenol Corporation has captured significant market attention in recent quarters, delivering a powerful combination of soaring orders, re ...
The equity of Bitcoin mining firm Riot Blockchain finds itself caught in a challenging crosscurrent. While the company ...
The semiconductor manufacturer Texas Instruments finds itself at the center of a significant legal storm. The company, along with peers Intel and AMD, and di ...
Shares of HVAC manufacturer Aaon have experienced a notable decline in December, shedding approximately 14% of their value ...
Investors in Ardelyx, the biopharmaceutical company, are currently weighing a conflicting set of signals. The equity's near-term trajectory appears uncertain ...
The defense contractor L3Harris Technologies is reinforcing its role in critical munitions supply chains through a significant contract extension and a key r ...
Duolingo Inc. (DUOL) is intensifying its efforts to drive user growth and loyalty through innovative gamification strategies ...
The Trade Desk is experiencing a correction of historic proportions. Shares of the programmatic advertising specialist have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results